Recall Register

Device recall: Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic

Class II FDA enforcement event 99389. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results; Increased rate of reaction cuvette QC failures and Delayed results due to QC failures.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Siemens Healthcare Diagnostics, Inc. started this device recall on 6 Jul 2026. The firm address in the FDA record is in Tarrytown, NY. FDA put the recall in Class II. FDA event 99389 has 1 product record. The first FDA enforcement report date is 12 Aug 2026. The record gives the status Ongoing. 291 of the 710 device events that started in 2026 have more product records. The median device event of 2026 has 1 product record.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution - US Nationwide including Puerto Rico and the countries of Australia, Austria, Bahamas, Belgium, Brazil, Canada, Chile, Curacao, St. Eus, Czech Republic, Denmark, Finland,…

Recalling firm

Siemens Healthcare Diagnostics, Inc., Tarrytown, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 99389: product records
Recall numberProductQuantityClassStatusReport date
Z-2890-2026Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic7018 unitsClass IIOngoing12 Aug 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2026
710
Share of these events in Class II
87%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
334

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 99389. https://recallregister.com/fda/ii/99389/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution - US Nationwide including Puerto Rico and the countries of Australia, Austria, Bahamas, Belgium, Brazil, Canada, Chile, Curacao, St. Eus, Czech Republic, Denmark, Finland,…
What quantity of product is in FDA event 99389?
The FDA record gives this quantity: 7018 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2026 have the same class?
87% of the 710 device events that started in 2026 are in Class II.